Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 50Neoplasm Metastasis 13Breast Neoplasms 9Carcinoma, Renal Cell 6Pain 5Osteoporosis 5Neoplasms 3Multiple Myeloma 3Kidney Neoplasms 3Lung Neoplasms 2Bone Neoplasms 2Bone Diseases, Metabolic 2Urologic Neoplasms 1Renal Insufficiency 1Insulin Resistance 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases 1

Interventions

Kidney Transplantation 3Paclitaxel 2Carboplatin 2vinflunine 1veliparib 1trifluridine tipiracil drug combination 1trebananib 1ripretinib 1pembrolizumab 1belantamab mafodotin 1Zoledronic Acid 1Urination 1Taxes 1Stents 1Standard of Care 1Sitagliptin Phosphate 1Polymerase Chain Reaction 1Oxaliplatin 1Nephrotomy 1Nephrostomy, Percutaneous 1Ice 1Health Information Exchange 1Gemcitabine 1Duration of Therapy 1Cyclosporine 1Cyclophosphamide 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Zoledronic Acid × Genitourinary × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡